Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6987781 | PMC |
| http://dx.doi.org/10.4103/ijem.IJEM_566_19 | DOI Listing |
Publication Analysis
Top Keywords
imatinib-induced gynecomastia
4
imatinib-induced
1
Similar Publications
Imatinib‑induced gynecomastia: A case report.
Exp Ther Med
November 2024
Department of Hematology, The First Affiliated Hospital of Jishou University, Jishou, Hunan 416000, P.R. China.
Article Synopsis
- * Imatinib is the main medication used to treat CML, known for its effectiveness but also for causing various side effects, including a rare condition called gynecomastia (breast tissue enlargement in males).
- * This report focuses on a case of a CML patient who developed gynecomastia from imatinib, emphasizing the need for healthcare providers to be aware of this side effect and to explore treatment options that minimize risks.
Imatinib-induced Gynecomastia.
Indian J Endocrinol Metab
January 2019
Department of Endocrinology, Christian Medical College and Hospital, Vellore, Tamil Nadu, India.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!